by Mark Chiang

马克·蒋

Share To

分享到

Archeus Technologies has entered into a partnership with the Wisconsin Alumni Research Foundation (WARF) to advance the development of ART-101, a receptor-based targeting molecule aimed at treating prostate cancer. The collaboration focuses on moving the therapeutic candidate into clinical development, marking a significant step in its progression toward potential use in medical treatment..

阿切乌斯科技公司已与威斯康星校友研究基金会（WARF）达成合作，以推动基于受体的靶向分子ART-101的开发，该分子旨在治疗前列腺癌。此次合作的重点是将这一治疗候选药物推进到临床开发阶段，标志着其在迈向潜在医疗应用的进程中迈出了重要一步。

Under the terms of the agreement, Archeus Technologies will take charge of leading Phase I clinical trials for ART-101. This phase will assess the safety and efficacy of the molecule in human subjects as part of its early-stage development. The partnership underscores efforts to address prostate cancer through innovative approaches, leveraging receptor-based targeting mechanisms to potentially improve treatment outcomes..

根据协议条款，阿基乌斯科技公司将负责领导ART-101的第一阶段临床试验。此阶段将评估该分子在人体受试者中的安全性和有效性，作为其早期开发的一部分。该合作强调了通过创新方法解决前列腺癌的努力，利用基于受体的靶向机制来潜在改善治疗结果。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

Date: Got it! Please provide the date you’d like me to format, and I’ll convert it for you.

日期：明白了！请提供您想要格式化的日期，我会为您转换。

Related posts:

相关文章：

Pharmaceutical Guide Helps Professionals Identify Key Similar Medicines to Inform Pricing Strategies.

药品指南帮助专业人士识别关键的类似药物，以制定定价策略。

Study Finds Mortality Prediction Tools Ineffective for Elderly Patients with Advanced Chronic Kidney Disease

研究发现，死亡率预测工具对晚期慢性肾病老年患者无效

Global Pharmaceutical Deal Activity Totals $6.96 Billion in May 2025 with Three Major Deals Driving 59 Percent of M&A Value

2025年5月，全球制药行业交易活动总额达到69.6亿美元，其中三大主要交易推动了59%的并购价值。

Extended Producer Responsibility Framework Requires Businesses to Ensure Packaging Recyclability and Disposal Accountability

延伸生产者责任框架要求企业确保包装可回收性和处置问责性

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 版权所有。与我们合作：

[email protected]

电子邮件地址

Author

作者

Mark Chiang

马克·江

Related Post

相关文章

News Flash

新闻快讯

Microbial Fermentation Gains Traction as Preferred Method for Biologics Production Due to Efficiency and Scalability

由于效率和可扩展性，微生物发酵作为生物制品生产的首选方法越来越受到关注。

2025-06-15

2025年6月15日